Low-dose chronic prenatal alcohol exposure abolishes the pro-cognitive effects of angiotensin IV by Fidalgo, Sara et al.
1	Introduction
In	humans,	prenatal	alcohol	exposure	(PAE)	can	cause	adverse	effects	on	the	brain	of	the	developing	foetus	and	can	result	in	a	wide	range	of	neurobehavioral	deficits,	encompassed	by	the	term	fetal	alcohol	spectrum	disorders
(FASD)	[1].	Fetal	alcohol	syndrome	(FAS)	is	considered	the	most	severe	form	of	these	disorders	and	is	characterised	by	offspring	displaying	neurodevelopmental	abnormalities	of	the	CNS,	such	as	small	head	size	at	birth;	structural
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Abstract
Prenatal	 ethanol	 exposure	 (PAE)	 in	 humans	 results	 in	 a	 spectrum	of	 disorders	 including	deficits	 in	 learning	 and	memory.	Animal	models	 to	 date	have	 typically	 used	high	 ethanol	 doses	 but	 have	not	 identified	 the
biochemical	changes	underlying	the	cognitive	deficit.	This	study	used	treatment	of	mouse	breeding	harems	with	5%	ethanol	via	drinking	water	throughout	pregnancy	and	lactation	and	explored	the	behavioural	consequences
in	the	progeny	at	3–6	months	of	age	using	the	open	field	test,	novel	object	recognition	test	and	elevated	plus	maze	to	measure	anxiety	and	memory	consolidation.	The	effects	of	angiotensin	IV	on	behaviour	of	the	progeny
were	also	determined.	The	results	indicated	that	PAE	increased	anxiety-like	behaviour	as	determined	in	the	open	field	test	in	male	but	not	female	progeny.	In	control	animals,	angiotensin	IV	enhanced	memory	consolidation	in
males,	but	this	effect	was	abolished	by	PAE.	The	abolition	of	the	pro-cognitive	effect	of	angiotensin	IV	was	not	a	consequence	of	increased	anxiety,	and	there	was	some	evidence	of	a	long-lasting	anxiolytic	effect	of	angiotensin
IV	in	the	male	PAE	progeny.	These	results	suggest	that	PAE	may	act	via	alteration	of	the	actions	of	the	brain	renin-angiotensin	system	to	impair	memory	consolidation,	but	these	effects	may	be	partially	sex-dependent.
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brain	abnormalities	and	specific	neurological	signs	(e.g.,	impaired	fine	motor	skills,	neurosensory	hearing	loss,	poor	tandem	gait,	poor	eye-hand	coordination,	cognitive	impairment).	Moreover	FAS	is	associated	with	growth	retardation,
such	as	low	birth	weight,	lack	of	weight	gain	over	time,	disproportional	low	weight	to	height	and	a	characteristic	pattern	of	facial	anomalies,	including	short	palpebral	fissures,	flat	upper	lip,	flattened	philtrum	and	flat	midface	[2,3].
Anxiety	has	also	been	associated	with	FAS	and	FASD,	with	the	offspring	commonly	displaying	depression-	and	anxiety-related	traits	[4,5].	Even	low	doses	of	alcohol	are	believed	to	be	able	to	generate	this	effect	[6,7].
The	risk	factors	for	FAS	are	unclear,	but	factors	such	as	socioeconomic	class,	ethnicity,	alcohol	metabolism	and	pattern	of	drinking	seem	to	be	important	[8].	There	are	many	difficulties	with	the	estimation	of	the	prevalence	of
FASD,	 but	 conservative	 figures	 suggest	 that	 it	 may	 be	 approximately	 2–7	 cases	 per	 1000	 live	 births	 in	 the	 developed	 world	 [9,10].	 Higher	 rates	 have	 been	 reported	 from	 countries	 with	 historically	 high	 prevalence	 of	 alcohol
consumption	[11].
Rodent	models	of	PAE	that	have	been	used	to	study	the	pathology	of	FASD	help	to	control	for	the	confounding	variables	that	exist	in	the	human	context	[12,13]	and	Sulik	and	her	group,	for	example,	have	demonstrated	a	clear
teratogenic	effect	of	ethanol	with	PAE	in	rats	being	associated	with	facial	dysmorphology	characteristic	of	FAS	[eg	14].	Rodent	models	of	FASD	have	been	created	with	numerous	ethanol	administration	methods,	from	inhalation	in
vapour	chambers	to	injections	(subcutaneous	or	intraperitoneal)	and	ingestion.	The	latter	has	proved	popular	with	groups	using	intragastric	gavage,	liquid	diet	models	or	voluntary	drinking	paradigms	[reviewed	in	15	and	16].	In	rats,
typical	oral	ethanol	doses	used	range	from	3	to	16	g/kg/day,	with	a	mode	of	approximately	5	g/kg/day.	In	mice,	typical	oral	ethanol	doses	used	range	from	5	to	24	g/kg/day,	with	a	mode	of	approximately	16	g/kg/day.	These	give	rise	to
blood	alcohol	concentrations	of	100–700	mg/100	ml	[12].	In	humans,	blood	alcohol	concentrations	of	approximately	400	mg/100	ml	are	seen	as	potentially	fatal	[17],	thus	not	all	of	these	models	are	realistically	reflective	of	the	human
situation.	Several	animal	models	of	FASD	have	identified	behavioural	deficits	associated	with	PAE	[18]	but	the	neurochemical	aetiology	of	FASD	remains	to	be	resolved	although	studies	using	in	vivo	and	in	vitro	models	have	highlighted
a	multitude	of	potential	mechanisms	by	which	PAE	disrupts	neurogenesis	and	causes	cell	death,	for	example	oxidative	stress,	disruption	of	growth	factors	(such	as	BDNF)	and	changes	in	the	transport	and	uptake	of	glucose	[19–21].
Animal	models	of	heavy	maternal	alcohol	consumption	and	binge-drinking	have	revealed	that	PAE	is	associated	with	impaired	performance	in	behavioural	tasks	that	assess	learning	and	memory	and	cognitive	deficits	[22–24].
Several	groups	have	investigated	cognition	enhancing	drugs	and	assessed	their	ability	to	reverse	the	deleterious	effects	of	prenatal	exposure	to	ethanol,	for	example	vitamin	E	and	the	anti-dementia	drug	memantine	[25,26].
One	such	cognition-enhancing	drug	is	the	peptide	angiotensin	IV,	a	component	of	the	renin-angiotensin	system	that	has	been	shown	to	have	beneficial	effects	on	memory	acquisition	and	recall	in	rats	and	mice	[27,28].	Both	central	and
peripheral	administration	of	angiotensin	 IV	has	been	shown	 to	 improve	novel	object	 recognition	 in	 rats	and	mice	 [28–31].	Furthermore	Pederson	et	al.	have	shown	 that	 it	 can	counteract	drug-induced	 impairment	of	 learning	and
memory	[32].	Together	these	studies	demonstrate	that	exogenous	administration	of	angiotensin	IV	can	enhance	learning	and	memory	in	healthy	rats	and	mice	and	reverse	memory	deficits	observed	in	animal	models	of	amnesia.	Human
trials	 have	 also	 demonstrated	 that	 drugs	 known	 to	 interfere	with	 the	 renin-angiotensin	 system,	 such	 as	 angiotensin-converting	 enzyme	 (ACE)	 inhibitors	 and	 angiotensin	 II	 receptor	 antagonists	 (AIIAs),	 also	 improve	 learning	 and
memory	in	ageing	patients	and	young,	healthy	volunteers	[33–35],	possibly	via	effects	on	angiotensin	IV	[36].
The	aim	of	this	study	was	to	explore	the	effects	of	angiotensin	IV	in	learning	and	memory	in	a	model	of	PAE	in	which	mice	were	exposed	to	5%	ethanol	in	the	drinking	water	throughout	pregnancy	and	suckling.	The	study	gives
some	insight	into	the	involvement	of	the	brain	renin-angiotensin	system	in	the	aetiology	of	the	cognitive	deficits	associated	with	FASD.
2	Materials	and	methods
2.1	Animal	husbandry
All	procedures	were	licenced	under	the	UK	Animals	(Scientific	Procedures)	Act	1986	and	EU	directive	2010/63/EU	and	complied	with	the	ARRIVE	guidelines.	They	were	approved	by	the	University	of	Brighton	animal	welfare
and	ethics	review	board.	C57BL/6J	mice	were	maintained	at	19.0	±	1	°C,	55%	humidity	and	fed	on	either	a	breeding	diet	(RM3	(E)	801002	chow,	Special	Diet	Services)	(breeding	harems)	or	a	maintenance	diet	(RM1	(E)	801002	chow,
Special	Diet	Services)	(offspring)	ad	libitum.	The	mice	were	maintained	on	a	12-h	light/dark	schedule,	lights	on	0700	h	(60	Lux	at	cage	level).	Behavioural	testing	was	conducted	between	1000	and	1500	h.
2.2	Prenatal	alcohol	exposure	(PAE)
Breeding	harems	were	established	with	one	male	to	two	females;	males	were	removed	from	the	cages	once	pregnancy	had	been	confirmed.	The	harems	received	fluid	ad	libitum	with	the	alcohol	exposure	groups	having	24	h
access	to	a	bottle	of	5%	ethanol	and	the	control	group	having	24	h	access	to	a	bottle	of	tap-water.	The	volume	of	liquid	consumed	by	each	harem	was	recorded	daily.	Because	the	number	of	mice	per	cage	varied	as	a	consequence	of	the
males	being	removed	on	confirmation	of	pregnancy	it	was	assumed	that	the	consumption	was	approximately	equal	between	different	mice	within	each	cage	in	order	to	estimate	individual	alcohol	consumption.	No	account	was	taken	of
litter	size	when	estimating	fluid	intake.	Offspring	were	weaned	at	20	days	and	group-housed	in	same-sex,	littermate	cages	with	free	access	to	food	and	tap-water.	Behavioural	assessments	were	made	of	the	control	and	PAE	progeny	at
3–6	months	of	age.
2.3	Blood	alcohol	concentration	determination
Blood	alcohol	concentration	was	determined	by	gas	chromatography.	Briefly,	blood	was	collected	by	cardiac	puncture	post	mortem	from	a	small	sample	of	male	and	female	ex-breeders	between	1100	h	and	1300	h.	 Plasma
samples	were	deproteinated	with	10%	trichloroacetic	acid	spiked	with	1%	ethanol	and	centrifuged	at	9400g	for	10	min.	The	supernatant	was	filtered	before	gas	chromatography	analysis.	Standards	and	samples,	both	with	an	internal
standard	(1%	propan-1-ol),	were	analysed	on	a	Perkin	Elmer	Clarus	500	gas	chromatograph	with	a	Zebron	Phase	(ZB-waxplus	column),	equipped	with	a	flame	ionization	detector.	The	optimal	operating	conditions	were	as	follows:	oven
temperature	35	°C	and	 flame	 ionisation	detector	 temperature	150	°C,	with	 the	 injection	 temperature	250	°C	 and	 the	 capillary	 temperature	 250	 °C;	 hydrogen	 and	 air	 pressure	were	 set	 at	 optimal	 conditions	 of	 58	psi	 and	 60psi,
respectively.
2.4	Behavioural	tests
All	behavioural	tests	were	conducted	within	a	sound-proof	chamber	(other	than	for	the	constant	hum	of	a	small	ventilation	fan).	The	lighting	was	constant	at	40	Lux,	slightly	below	that	of	the	home	cage.	The	experimental
protocol	was:
Time	0	h:	3	min	exposure	to	open	field.
Time	1	h:	First	3-min	training	period,	novel	object	recognition	test.
Time	2	h:	Second	3-min	training	period,	novel	object	recognition	test,	followed	immediately	by	administration	of	angiotensin	IV	or	vehicle	control.
Time	26	h:	3-min	novel	object	discrimination	period.
Time	27	h:	3-min	elevated	plus	maze.
Within	all	experimental	sessions,	different	treatment	groups	(i.e.	control	vs	PAE;	saline	vs	angiotensin	IV)	were	alternated	to	remove	any	environmental/time	of	day	confounding	effects.
2.4.1	Open	field	test
Mice	were	placed	inside	the	open	field	(34	×	60	cm)	and	allowed	3	min	to	explore	the	area	before	being	returned	to	their	home	cage.	The	field	was	cleaned	with	70%	ethanol	before	the	test	session	and	between	each	animal.	The	behaviour	was
video	recorded	and	analysed	using	Ethovision	software	to	track	total	distance	moved	during	each	trial	and	the	time	spent	with	the	centre-point	of	the	animal	within	5	cm	from	the	walls	of	the	apparatus	(thigmotaxis).
2.4.2	Novel	object	recognition
The	novel	object	recognition	test	was	adapted	from	the	protocol	previously	described	[37].	Briefly,	1	h	following	the	open	field	test	the	mice	were	returned	to	the	same	field	(34	×	60	cm)	into	which	two	identical	objects	(plastic	building	blocks)
were	positioned	at	one	end	of	the	field,	each	5	cm	from	the	adjacent	walls.	The	mice	were	allowed	to	explore	the	field	and	objects	for	3	min	before	being	returned	to	their	home	cage.	The	mice	were	again	exposed	to	the	field	and	familiar	objects	one	hour
later.	Immediately	after	the	second	familiarisation	trial	the	mice	were	treated	with	angiotensin	IV	(5	μg/kg,	s.c.,	Bachem	AG)	or	saline	control,	all	at	10	ml/kg,	before	being	returned	to	their	home	cage	for	24	h.
For	the	final	(discrimination)	trial,	one	of	the	objects	was	replaced	with	a	novel	(different	shape	and	colour)	object,	and	the	mice	were	again	given	3	min	to	explore	the	field	and	objects.	Novel	objects	were	replaced,	left	and	right,	on	an	alternate
basis	to	remove	bias.	Both	the	field	and	objects	were	cleaned	with	70%	ethanol	between	each	animal	during	all	stages	of	the	procedure.	At	all	stages	the	animal	behaviour	was	video	recorded	and	analysed	using	Ethovision	software	to	track	total	distance
moved	during	each	trial	and	the	time	spent	with	the	nose-point	of	the	animal	within	5	mm	of	each	of	the	objects:	the	definition	of	object	exploration	as	defined	by	[38].
2.4.3	Elevated	plus	maze
The	elevated	plus	maze	was	used	to	assess	anxiety	in	mice	one	hour	after	the	novel	object	recognition	test	discrimination	trial,	25	h	after	angiotensin	IV	administration.	Briefly,	mice	were	placed	onto	an	elevated	cruciform	runway,	with	four	arms
(each	approximately	8	cm	wide	and	30	cm	long).	Two	opposite	arms	were	enclosed	by	high	walls	(approximately	15	cm	high),	and	the	other	two	arms	were	open.	The	runway	was	elevated	1	m	from	the	floor.	Mice	were	placed	in	the	centre	zone	of	the	maze
and	left	to	explore	for	3	min,	after	which	they	were	returned	to	their	home	cage.	As	with	the	previous	tests,	the	maze	was	cleaned	with	70%	ethanol	between	each	animal.	At	all	stages	the	behaviour	was	recorded	and	analysed	using	Ethovision	software	to
track	total	distance	moved	during	each	trial	and	the	time	spent	in	both	open	and	closed	arms.
2.5	Behavioural	statistical	analysis
The	distribution	of	data	were	assessed	for	normality	using	the	Kolmogorov-Smirnov	test.
Data	for	fluid	intake,	body	weight	and	total	distance	moved	on	the	elevated	plus	maze	were	found	to	be	normally	distributed	and	values	are	expressed	as	group	means	±	standard	error	of	the	mean	(sem).	Comparison	of	group
means	was	by	Student’s	t-test	where	two	groups	were	compared	or	by	one-way	or	two-way	analysis	of	variance	(ANOVA),	followed	by	post-hoc	tests	as	appropriate,	where	more	than	two	groups	were	compared.
Data	for	locomotor	activity	within	the	open	field,	thigmotaxis,	distance	moved	and	time	spent	exploring	objects	in	the	novel	object	recognition	test	and	time	spent	exploring	the	open	arms	in	the	elevated	plus	maze	were	found
not	to	be	normally	distributed.	Data	are	presented	as	box	plots	which	display	median	value,	interquartile	range	and	maxima	and	minima	and	outliers.	Group	data	for	paired	and	unpaired	values	were	compared	using	the	Mann-Witney
and	Wilcoxon	tests	respectively	where	two	groups	were	compared	and	the	Kruskal-Wallis	test	were	more	than	two	groups	were	compared.
A	p	value	<0.05	was	considered	to	be	statistically	significant.
3	Results
3.1	Alcohol	intake	and	blood	alcohol	concentrations
Daily	 fluid	consumption	 (calculated	per	animal)	was	 recorded	 for	 two	breeding	harems	of	each	 treatment	group	over	10	weeks	during	which	each	harem	produced	 two	 litters.	Two-way	ANOVA	confirmed	 that	 there	were
significant	changes	in	fluid	intake	over	time	(p	=	0.0022)	and	that	there	was	a	significant	difference	between	the	two	treatment	groups	(p	=	0.0052,	Fig.	1).	The	mean	daily	volume	of	fluid	ingested	per	animal	was	significantly	lower	in
the	alcohol	group	compared	to	control	(7.10	±	0.70	ml	v	10.04	±0.47	ml).	Fluid	intake	varied	throughout	the	10	week	period,	from	a	baseline	of	approximately	5	ml	per	day	in	the	alcohol	group	at	the	start	of	the	study	to	a	maximum	of
12	ml	per	day	in	late	pregnancy/lactation.	Only	2	of	the	4	animals	sampled	had	measurable	blood	ethanol	concentrations	between	1100	h	and	1300	h.	These	two	samples	had	highly	disparate	values	of	87.5	and	0.294	mg/100	ml.	The
group	mean	blood	alcohol	concentration	was	thus	21.95	±	21.85	mg/100	ml.
3.2	Progeny	body	weight
Progeny	weight	was	monitored	immediately	before	behavioural	testing,	for	both	males	and	females	(Fig.	2).	There	was	a	significant	difference	between	the	sexes	(P	<	0.0001,	2-way	ANOVA)	but	no	significant	difference	in	body
weight	between	the	different	treatment	groups	for	either	male	or	female	offspring,	nor	significant	sex	x	treatment	interaction.
Fig.	1	Maternal	drinking	patterns,	expressed	as	estimated	mean	volume	intake	per	mouse,	over	the	10	week	breeding	period.	Litters	were	delivered	at	approximately	4	and	9	weeks.	Data	shown	as	mean	±	S.E.M	of	two	cages	of	2–3	animals	per	group,	the	alcohol	group	drank
significantly	less	than	the	control	group	over	the	duration	of	the	study	(p	<	0.01	2-way	ANOVA).
alt-text:	Fig.	1
Fig.	2	Weights	of	control	and	pre-natal	alcohol-exposed	male	and	female	mice	at	the	time	of	behavioural	experiments	(3–6	months	of	age).	No	significant	differences	in	weight	were	detected	in	either	male	or	female	progeny,	although	there	was	a	significant	difference	in	body	weight
between	males	and	females.	Data	shown	as	mean	±	S.E.M.	of	indicated	sample	sizes	(***	p	<	0.0001).
3.3	Open	field	test
There	were	 no	 significant	 effects	 of	 PAE	 on	 locomotor	 activity	within	 the	 open	 field	 in	 either	male	 or	 female	 offspring	 (Fig.	 3A).	With	 respect	 to	 the	 percentage	 time	 the	mice	 spent	 close	 to	 the	walls	 of	 the	 open	 field
(thigmotaxis)	all	mice	showed	a	tendency	to	avoid	the	open	centre-ground.	In	male	offspring	the	pre-natal	alcohol	exposure	significantly	 increased	thigmotaxis	(p	<	0.001,	Mann-Whitney	test,	Fig.	3B)	but	this	was	not	the	case	for
female	offspring.
3.4	Novel	object	recognition
Within	the	novel	object	recognition	test,	there	was	no	significant	effect	of	prenatal	alcohol	exposure	nor	angiotensin	IV	treatment	on	total	distance	moved	within	the	3	min	of	the	test	(discrimination	trial)	(Kruskal-Wallis	test,
Fig.	4A).
alt-text:	Fig.	2
Fig.	3	Effect	of	pre-natal	alcohol	exposure	on	locomotor	activity	and	thigmotaxis	during	the	open	field	test	in	male	and	female	progeny.	(A)	There	were	no	significant	effects	of	PAE	on	locomotor	activity	in	male	or	female	offspring.	(B)	In	male	progeny,	PAE	resulted	in	significantly
greater	thigmotaxis;	there	was	no	effect	of	pre-natal	alcohol	exposure	in	female	progeny.	Box	plots	represent	median	value	and	interquartile	range,	whiskers	represent	maxima	and	minima.	+	represents	outliers.	n	=	36	for	control	males,	38	for	PAE	males,	12	for	control	females	and
24	for	PAE	females	(**	p	<	0.001,	Mann-Whitney	test).
alt-text:	Fig.	3
Fig.	4	The	effects	of	pre-natal	alcohol	exposure	and	24-h	pre-treatment	with	angiotensin	IV	(5	μg/kg	s.c.,	Ang	IV)	on	the	behaviour	of	male	and	female	mice	in	the	novel	object	recognition	test.	(A)	Illustrates	that	neither	pre-natal	alcohol	exposure	nor	24-h	pre-treatment	with	ang	IV
significantly	influenced	locomotor	activity	in	the	novel	object	recognition	test	in	either	sex	progeny.	(B)	Illustrates	that	in	the	control	groups,	male	mice	discriminated	significantly	between	the	novel	and	familiar	object	only	after	ang	IV	pre-treatment	and	female	progeny	discriminated
significantly	between	novel	and	familiar	objects	only	after	saline	vehicle	pre-treatment.	(C)	Illustrates	that	neither	male	nor	female	progeny	exposed	to	pre-natal	alcohol	discriminated	significantly	between	novel	and	familiar	objects	even	after	ang	IV	pre-treatment.	Box	plots
represent	median	value	and	interquartile	range,	whiskers	represent	maxima	and	minima.	+	represents	outliers.	n	=	16-20	for	control	males	and	females	and	8	for	PAE	males	and	females	(*	p	<	0.05	and	**	p	<	0.001,	Mann-Whitney	test).
alt-text:	Fig.	4
With	respect	to	the	paired	analysis	of	the	exploration	of	the	familiar	and	novel	objects,	the	results	demonstrated	that	the	male	control	progeny	showed	no	significant	discrimination	between	novel	and	familiar	objects	following
treatment	with	saline	vehicle,	but	significantly	greater	exploration	of	the	novel	object	following	pre-treatment	with	angiotensin	IV	(p	=	0.049,	Wilcoxon	test,	Fig.	4B).	In	male	PAE	progeny,	again	there	was	no	significant	discrimination
between	novel	and	familiar	objects	by	those	animals	pre-treated	with	saline	vehicle,	but	the	pre-natal	ethanol	exposure	abolished	the	effects	of	angiotensin	IV	pre-treatment	on	object	discrimination	that	had	been	seen	in	the	non-PAE
group	(Fig.	4C).
In	 female	control	progeny,	animals	pre-treated	with	saline	vehicle	discriminated	between	 the	novel	and	 familiar	objects	 (p	=	0.009,	Wilcoxon	 test,	Fig.	4B),	 but	 those	pre-treated	with	 angiotensin	 IV	 showed	no	 significant
discrimination.	In	female	progeny	exposed	pre-natally	to	ethanol,	neither	the	saline	vehicle	group	nor	the	group	that	received	angiotensin	IV-pre-treatment	showed	any	discrimination	between	novel	and	familiar	objects	(Fig.	4C).
With	respect	to	the	total	time	spent	exploring	the	objects	(familiar	+	novel	objects),	there	was	a	significant	effect	of	prenatal	ethanol	exposure	on	total	exploration	within	the	3	min	of	the	test	(discrimination	trial)	with	PAE
reducing	distance	moved	in	both	male	and	female	offspring	(p	=	0.004	and	0.001	respectively,	Kruskal-Wallis	test).	There	was	no	significant	main	effect	of	pre-treatment	with	angiotensin	IV	on	total	exploration	of	objects	in	either	male
or	female	offspring.
3.5	Elevated	plus	maze
In	the	male	progeny,	the	total	distance	moved	as	part	of	the	elevated	plus	maze	test	was	significantly	greater	in	the	PAE	animals	than	the	controls	(p	=	0.02	2-way	ANOVA,	Fig.	5A).	There	was	no	significant	influence	of	the
angiotensin	IV	pre-treatment	nor	was	there	a	significant	interaction.	In	female	progeny	there	was	no	significant	effect	of	PAE	nor	angiotensin	IV	pre-treatment	on	total	distance	moved.
With	respect	to	time	spent	on	the	open	arms,	in	male	progeny	there	was	no	significant	effect	of	angiotensin	IV	pre-treatment	in	the	control	animals,	but	angiotensin	IV	pre-treatment	significantly	increased	the	time	on	the	open
arms	in	the	alcohol-treated	animals	(p	=	0.0014,	Mann-Whitney	test,	Fig.	5B).
In	the	female	progeny,	neither	pre-natal	alcohol	exposure	nor	angiotensin	IV	pre-treatment	had	any	significant	effect	on	time	spent	on	the	open	arms	of	the	elevated	plus	maze.
4	Discussion
This	study	investigated	the	effect	of	low	dose	alcohol	exposure	throughout	pregnancy	and	suckling	on	the	behaviour	of	the	adult	offspring.	The	average	ethanol	intake	per	breeding	female	was	approximately	11	g/kg/day.	Other
groups	using	single	bottle	models	have	reported	average	consumptions	of	10–14	g/kg/day	[39,40].	Taking	into	account	the	different	apparent	volumes	of	distribution	for	ethanol	(total	body	water)	in	female	humans	and	mice	(0.63	l/kg	v.
Fig.	5	The	effects	of	pre-natal	alcohol	exposure	and	25-h	pre-treatment	with	angiotensin	IV	(5	μg/kg	s.c.,	Ang	IV)	on	the	behaviour	of	male	and	female	mice	on	the	elevated	plus	maze.	(A)	Pre-natal	exposure	to	alcohol	caused	a	significant	increase	in	distance	moved	in	the	male	but
not	female	progeny	(*	p	<	0.05).	(B)	Pretreatment	with	angiotensin	IV	had	no	significant	effect	on	the	time	spent	on	the	open	arms	in	either	male	or	female	contraol	progeny.	IN	PAE	animals,	angiotensin	IV	significantly	increased	the	time	spent	in	the	open	arms	in	male	progeny	but
not	female.	Box	plots	represent	median	value	and	interquartile	range,	whiskers	represent	maxima	and	minima.	+	represents	outliers.	n	=	7–12	for	control	males	and	females	and	7–8	for	PAE	males	and	females	(*	p	<	0.05,	Mann-Whitney	test).
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0.8	l/kg)	 and	 the	greater	 rate	 of	 ethanol	 elimination	 in	mice	 [41],	 the	 ethanol	 intake	 in	 the	 current	 study	 equates	 to	 a	 human	daily	 ethanol	 intake	 of	 approximately	 100	g,	 the	 equivalent	 of	 one	 bottle	 of	 table	wine.	 These	 daily
consumptions	in	mice	have	been	reported	as	resulting	in	blood	alcohol	concentrations	averaging	80–120	mg/100	ml	[24,39].	Our	results	identified	concentrations	significantly	lower	than	these,	which	could	be	explained	by	rodents
drinking	primarily	during	the	dark	phase	(which	in	the	current	would	be	1900–0700	h)	compared	to	blood	sampling	some	5	h	later.	Allan	et	al.	[39]	monitored	blood	alcohol	concentrations	of	B6SJL/F1	mice	over	a	24	h	period	(with
lights	on	0700–1900)	and	found	that	administration	of	14	g/kg/day	of	ethanol,	resulted	in	peak	blood	alcohol	concentrations	of	140	mg/100	ml	at	approximately	0100	h	and	minimum	concentrations	of	50	mg/100	ml	between	0900	and
1200	h.	Our	blood	collection	was	conducted	at	the	time	of	lowest	blood	alcohol	and	it	revealed	very	variable	blood	alcohol	concentrations,	although	a	mean	of	approximately	22	mg/100	ml	clearly	indicates	that	our	11	g/kg/day	average-
model	results	in	lower-dose	exposure	to	alcohol	than	the	14/g/kg/day.	Another	difference	between	the	current	study	and	that	of	Allen	et	al.	[39]	may	be	mouse	strain:	C57BL/6J	versus	B6SJL/FI,	although	the	latter	were	derived	from	the
former.
In	humans,	FASD	is	associated	with	decreased	body	weight	and	retarded	growth	[2].	The	results	of	the	current	mouse	model	study	failed	to	find	any	effect	of	the	low	dose	PAE	on	offspring	body	weight	at	3–6	months.	Such
results	are	in	keeping	with	the	work	of	Kaninen-Ahoha	et	al.	[42]	who	used	cross-fostering	to	show	that	pre-natal	exposure	of	C57/BL6J	mice	to	11	g/kg/day	from	gestational	days	1–8.5	resulted	in	significantly	decreased	body	weight	at
age	21	days	that	was	not	a	result	of	poor	maternal	behaviour,	but	that	there	was	no	significant	effect	on	body	weight	after	5	weeks	of	age.	In	rats,	however,	treatment	of	dams	throughout	pregnancy	and	lactation	with	4.5	g/kg/day
resulted	in	significantly	decreased	weights	in	male	offspring	at	3	months,	but	no	differences	in	female	offspring	[43].	These	combined	results	suggest	a	species	difference	in	the	effects	of	PAE	on	body	weight	but	support	the	current
mouse	model	of	PAE	as	being	similar	to	those	of	others.
With	respect	to	the	behavioural	findings,	Human	FASD	has	been	associated	with	hyperactivity	[1],	and	this	has	also	been	shown	in	one	mouse	model	using	exposure	to	10%	ethanol	in	drinking	water	from	gestational	days	0–8
using	the	open	field	test	[44].	A	lower	dose	of	ethanol,	6	g/kg/day	from	gestational	days	6–15,	however	has	been	shown	to	significantly	decrease	locomotor	activity	in	the	open	field	test	[45].	At	the	exposure	concentration	utilised	in	the
current	study	there	was	no	evidence	of	hyper-	nor	hypo-activity	of	the	progeny	with	no	significant	effect	of	pre-natal	ethanol	exposure	on	total	activity	in	the	open	field	test,	nor	the	novel	object	recognition	test	in	either	male	or	female
progeny.
Human,	 FASD	 has	 also	 been	 associated	with	 an	 increase	 in	 clinically-relevant	 anxiety	 [5].	 In	 our	mouse	model	 the	 open	 field	 test	 revealed	 an	 increase	 in	 anxiety	 in	male	 PAE	 offspring,	 as	 determined	 by	 the	 extent	 of
thigmotaxis.	Female	offspring	did	not	appear	to	be	affected	in	the	same	way	but	the	sex	difference	may	have	been	a	result	of	a	‘ceiling’	effect;	both	males	and	females	showed	marked	thigmotaxis,	in	the	region	of	90%,	but	with	the
control	female	mice	showing	greater	thigmotaxis	than	the	control	males.	This	high	basal	value	in	females	may	have	precluded	identification	of	any	additional	anxiety-like	behaviour	of	PAE	using	this	model.	Such	PAE-elevated	anxiety
has	been	seen	in	other	animal	models,	for	example	mandarin	voles	treated	orally	with	750	mg/kg	ethanol	daily	from	gestational	day	14	to	postnatal	day	1	and	Swiss	albino	mice	treated	with	6	g/kg/day	ethanol	from	gestational	days
6–15	[45,46].
The	findings	of	the	novel	object	recognition	test	need	to	be	considered	from	several	perspectives:	Firstly,	the	parameters	chosen	(two	3-min	training	sessions	and	a	recall	session	24	h	later)	do	not	typically	demonstrate	any
learning	within	the	control	mice	[37].	The	aim	of	this	series	of	experiments	was	therefore	to	ascertain	the	effects	of	PAE	on	the	effects	of	angiotensin	IV.	Angiotensin	IV	has	previously	been	shown	to	enhance	cognition	using	the	above-
mentioned	paradigm	[37].	Secondly,	 analysis	 of	 the	 results	 for	 the	non-angiotensin	 IV-treated	animals	 allows	 some	consideration	of	 the	effects	 of	PAE	on	exploratory	 and	 inquisitive	behaviour.	Finally,	 in	 the	 light	 of	 the	 fact	 that
angiotensin	IV	is	known	to	bind	to	the	angiotensin	AT1	receptor,	that	AT1	receptor	stimulation	has	been	shown	to	have	anxiogenic	effects	[47]	and	that	anxiety	will	confound	learning	and	memory	assessments,	the	results	need	to	be
considered	in	tandem	with	a	timely	assessment	of	anxiety-like	behaviour.	The	use	of	the	elevated	plus	maze	one	hour	after	the	novel	object	recognition	test	recall	trial	was	designed	to	fulfil	this	need.
The	results	showed	that	within	the	animals	that	did	not	receive	pre-treatment	with	angiotensin	IV	(saline	treated),	PAE	had	no	significant	effect	on	total	distance	moved	in	either	male	or	female	offspring.	These	results	indicate
that	PAE	causes	neither	long	lasting	sedation	nor	motor	deficits	and	are	in-line	with	the	findings	of	the	open	field	test.	Similarly,	there	was	no	significant	main	effect	of	angiotensin	IV	pre-treatment	in	either	males	or	female	offspring
indicating	that	angiotensin	IV	does	not	have	any	marked	stimulant	nor	sedative	effect,	nor	does	it	induce	any	motor	disruption.
When	considering	the	differentiation	of	the	familiar	and	novel	objects,	the	results	indicate	that	male	mice	treated	with	saline	showed	no	significant	discrimination.	Following	treatment	with	angiotensin	IV,	however,	the	mice
differentiated	 significantly	between	 the	novel	 and	 familiar	 objects.	This	 result	 replicates	 our	 earlier	 findings	 [37].	Female	mice,	however,	behaved	quite	differently:	 those	animals	 receiving	 saline	 vehicle	demonstrated	 significant
differentiation,	 a	 result	 not	 unique	 in	 our	 laboratory,	 but	 not	 typical.	 Following	 treatment	with	 angiotensin	 IV	 the	 discrimination	was	 lost;	 our	 previous	work	 in	male	mice	 demonstrated	 loss	 of	 discrimination	 at	 higher	 doses	 of
angiotensin	IV	[37],	thus	this	result	may	represent	some	form	of	high	dose	effect	with	some	other	action	of	angiotensin	IV	becoming	apparent.
In	those	males	pre-natally	exposed	to	ethanol,	the	pro-cognitive	effects	of	angiotensin	IV	were	lost,	suggesting	that	PAE	prevents	the	effects	of	angiotensin	IV	on	memory	consolidation.	Importantly,	however,	PAE	significantly
decreased	the	total	time	exploring	the	objects	in	both	saline-	and	angiotensin	IV	pre-treated	male	and	female	offspring.	Whether	this	reduction	in	exploratory	and	inquisitive	behaviour	by	PAE	explains	the	loss	of	efficacy	of	angiotensin
IV	remains	to	be	clarified,	but	taken	with	the	OFT	results	it	does	suggest	that	the	animals	have	similar	locomotor	activity	but	less	targeted	exploration,	possibly	a	consequence	of	the	thigmotaxis.
Results	of	the	elevated	plus	maze	assessment	conducted	shortly	after	the	novel	object	recognition	test	are	confusing.	There	is	no	evidence	of	increased	anxiety-like	behaviour,	as	determined	by	decreased	time	spent	on	the	open
arms	of	the	maze,	in	either	male	or	female	control	or	PAE	offspring.	Furthermore,	27-h	pre-treatment	with	angiotensin	IV	did	not	increase	anxiety-like	behaviour	in	any	of	the	treatment	groups.	It	can	therefore	be	stated	confidently
that	the	observed	PAE-induced	deficits	in	novel	object	recognition	test	were	not	a	consequence	of	increased	anxiety-like	behaviour.	The	elevated	plus	maze	results	do,	however,	indicate	that	PAE	together	with	27-h	pre-treatment	with
angiotensin	IV	reduces	anxiety-like	behaviour	in	male	offspring.	This	is	against	the	preliminary	expectation	because,	as	described	above,	it	was	predicted	that	angiotensin	IV,	acting	via	AT1	receptors	would	increase	anxiety.	The	renin
angiotensin	system	has	been	previously	linked	to	anxiety,	with	angiotensin	II	having	an	anxiogenic	effect	and	angiotensin	receptor	(AT1)	antagonists	and	ACE	inhibitors	having	an	anxiolytic	effect	[48–50].	Moreover,	the	AT1	but	not	AT2
receptors	are	thought	to	be	involved	in	increased	anxiety	[48].	Previous	work	exploring	the	effects	of	angiotensin	II	and	its	antagonists	on	anxiety-like	behaviour	has	also	indicated	a	time-dependent	response,	suggesting	some	element
of	‘rebound’	effect	at	3	h	post-dose,	and	a	complex	interplay	of	AT1	and	AT2-mediated	effects	[47].	Evidence	of	reduced	anxiety-like	behaviour	27-h	after	a	predictably	anxiogenic	dose	of	angiotensin	IV	is	therefore	novel.
Many	studies	have	 looked	at	the	effect	of	PAE	in	spatial	response	and	memory	 in	rodents.	For	example,	a	study	 in	C57BL/6J	mice	has	found	long	lasting	 learning	and	memory	deficits	 in	delay	fear	conditioning,	trace	fear
conditioning	and	radial-maze	tasks	with	no	changes	in	spontaneous	locomotor	activity	in	90	and	150	day	old	male	offspring	[24].	However,	there	have	been	very	few	studies	looking	at	PAE	and	novel	object	recognition,	with	Popović	et
al.	[51]	showing	that	pre	and	postnatal	exposure	to	5%	ethanol	in	Wistar	rats	caused	a	significant	impairment	in	spatial	learning	and	object	recognition.	Another	study	in	C57BL/6J	mice	showed	that	prenatal	exposure	to	25%	ethanol
on	gestational	day	8	 caused	 significant	 spatial	memory	 impairments	as	well	 as	 impaired	object	 recognition	 in	60	day	 old	mice	 (52).	 The	 aim	of	 the	 current	 study	was	 to	 explore	 the	 effects	 of	 PAE	on	 the	pro-cognitive	 effects	 of
angiotensin	IV	as	determined	by	novel	object	recognition.
The	mechanism	of	the	pro-cognitive	effect	of	angiotensin	IV	is	unclear	but	it	is	known	that	it	binds	to	insulin-regulated	aminopeptidase	(IRAP)	[53].	IRAP	possesses	aminopeptidase	activity	and	is	responsible	for	the	cleavage	of
endogenous	peptides	such	as	vasopressin	and	oxytocin	but	it	is	also	associated	with	the	GLUT4	glucose	transported	and,	in	combination	with	insulin,	increases	glucose	uptake	into	cells;	angiotensin	IV	inhibits	the	enzyme	activity	but
enhances	glucose	uptake	[reviewed	in	54].	Harding	and	Wright,	however,	argue	that	another	potential	mechanism	of	action	is	dependent	on	activation	of	the	hepatocyte	growth	factor/c-MET	system	[55].	PAE	prevents	the	pro-cognitive
effects	of	 angiotensin	 IV	 in	male	offspring,	 suggesting	 some	disruption	of	 the	binding	 sites	and/or	processes	underlying	 its	procognitive	effects,	 or	possibly	 some	disruption	of	 the	 synthesis	 or	 enhancement	of	 the	metabolism	of
angiotensin	IV	itself.	These	possibilities	warrant	further	 investigation	although	it	 is	known	that	PAE	can	impact	 insulin	signalling	molecules	in	guinea-pigs	[56]	and	in	another	condition	associated	with	memory	deficit,	Alzheimer’s
disease,	plasma	concentrations	of	the	putative	receptor	for	angiotensin	IV,	IRAP,	has	been	shown	to	be	decreased,	as	have	aminopeptidases	A,	B	and	N,	which	are	involved	in	synthesis	of	angiotensin	IV	[57].	The	possibility	therefore
exists	that	PAE	may	induce	deficits	in	learning	and	memory	at	least	partially	by	disruption	of	the	synthesis/action	of	endogenous	angiotensin	IV.
An	additional	underlying	theme	of	this	study	has	been	the	sex-dependent	nature	of	the	results	seen.	Few	studies	have	used	female	progeny	in	learning	and	memory	tests	and	neither	Popović	et	al.	[51]	nor	Summers	et	al.	[52]
discriminated	between	male	and	 female	progeny.	Despite	 this	 lack	of	behavioural	evidence,	other	studies	have	shown	that	PAE	has	gender	specific	effects,	with	 long-term	potentiation	being	reduced	 in	 the	male	but	not	 in	 female
progeny	[58].	Furthermore,	the	renin	angiotensin	system,	and	in	particularly	ACE	activity	is	reported	to	have	sex	differences	[59].	Interestingly	a	recent	study,	using	a	model	of	attention	deficit	disorder,	has	also	shown	an	effect	of	ACE
inhibitors	 in	male	but	not	female	mice,	giving	further	evidence	for	sex	differences	 in	the	brain	renin-angiotensin	system	[60].	In	the	current	study,	anxiety-like	behaviour	as	determined	by	the	elevated	plus	maze	conducted	at	the
conclusion	of	two-day	behavioural	test-battery	for	the	animals,	indicated	reduced	anxiety	in	male	offspring	only.	In	the	open	field	test,	conducted	at	the	start	of	the	test	battery,	the	results	suggested	elevated	anxiety	induced	by	PAE	in
male	offspring	only.	Recent	evidence	in	humans	has	indicated	that	FASD	is	more	prevalent	in	males	than	females	[61],	the	results	of	this	mouse	model	of	PAE	therefore	appears	to	be	reflective	of	the	human	condition	in	that	some
degree	of	sex-dependence	has	been	identified.
In	conclusion,	the	results	of	this	study	suggest	that	administration	of	5%	ethanol	via	drinking	water	throughout	pregnancy	and	lactation	in	mice	is	a	reflective	model	of	FASD	in	humans	and	that	the	results	suggests	that	PAE
disrupts	the	actions	of	exogenous	angiotensin	IV	which	may	be	a	mechanism	responsible	for	the	impaired	learning	and	memory	and	possibly	a	future	target	for	potential	therapies.
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